【结 构 式】 |
【分子编号】16422 【品名】methyl (1R,4S)-7-azabicyclo[2.2.1]hept-2-ene-7-carboxylate 【CA登记号】 |
【 分 子 式 】C8H11NO2 【 分 子 量 】153.18088 【元素组成】C 62.73% H 7.24% N 9.14% O 20.89% |
合成路线1
该中间体在本合成路线中的序号:rac-(LVI)14) It is noteworthy that Regan et al. described a very concise synthesis of racemic epibatidine. The key step was a reductive Pd-catalyzed Heck-type coupling of the known starting materials olefin (LVI) and 2-chloro-5-iodopyridine (LVII). The desired exo-isomer (LVIII) was formed stereoselectively.
【1】 Clayton, S.C.; Regan, A.C.; A total synthesis of (±)-epibatidine. Tetrahedron Lett 1993, 34, 7493-6. |
【2】 Bai, D.; Xu, R.; Zhu, X.; Epibatidine. Drugs Fut 1997, 22, 11, 1210. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
rac-(LIV) | 16420 | methyl (1S,4R)-2-[(4-methylphenyl)sulfonyl]-7-azabicyclo[2.2.1]hepta-2,5-diene-7-carboxylate | C15H15NO4S | 详情 | 详情 | |
rac-(LV) | 16421 | methyl (1S,4R)-2-[(4-methylphenyl)sulfonyl]-7-azabicyclo[2.2.1]hept-2-ene-7-carboxylate | C15H17NO4S | 详情 | 详情 | |
rac-(LVI) | 16422 | methyl (1R,4S)-7-azabicyclo[2.2.1]hept-2-ene-7-carboxylate | C8H11NO2 | 详情 | 详情 | |
rac-(LVII) | 16424 | methyl (1R,2R,4S)-2-(6-chloro-3-pyridinyl)-7-azabicyclo[2.2.1]heptane-7-carboxylate | C13H15ClN2O2 | 详情 | 详情 | |
(LVII) | 16423 | 2-chloro-5-iodopyridine | C5H3ClIN | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(II)Intermediate (III) was prepared by condensation of epoxide (I) with piperazine (II). After removal of the carbobenzoxy protecting group of (III) by catalytic hydrogenation, the resulting amine (IV) was coupled to the valine derivative (V) using EDC to afford amide (VI). Subsequent cleavage of the Boc protecting group of (VI) under acidic conditions gave (VII), which was finally alkylated with the benzodioxolylmethyl halide (VIII) to provide the target compound.
【1】 Chen, X.; Kempf, D.J.; Sham, H.L.; Green, B.E.; Molla, A.; Korneyeva, M.; Vasavanonda, S.; Wideburg, N.E.; Saldivar, A.; Marsh, K.C.; McDonald, E.; Norbeck, D.W.; Potent piperazine hydroxyethylamine HIV protease inhibitors containing novel P3 ligands. Bioorg Med Chem Lett 1998, 8, 24, 3531. |
【2】 Chen, X.; Mohammadi, F.; Norbeck, D.W.; Kempf, D.J. (Abbott Laboratories Inc.); Retroviral protease inhibiting cpds.. WO 9959994 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 14522 | benzyl N-[(1S)-1-[(2S)oxiranyl]-2-phenylethyl]carbamate | C18H19NO3 | 详情 | 详情 | |
(II) | 16422 | methyl (1R,4S)-7-azabicyclo[2.2.1]hept-2-ene-7-carboxylate | C8H11NO2 | 详情 | 详情 | |
(III) | 30251 | tert-butyl (3S)-4-((2R,3S)-3-[[(benzyloxy)carbonyl]amino]-2-hydroxy-4-phenylbutyl)-3-[(tert-butylamino)carbonyl]-1-piperazinecarboxylate | C32H46N4O6 | 详情 | 详情 | |
(IV) | 30252 | tert-butyl (3S)-4-[(2R,3S)-3-amino-2-hydroxy-4-phenylbutyl]-3-[(tert-butylamino)carbonyl]-1-piperazinecarboxylate | C24H40N4O4 | 详情 | 详情 | |
(V) | 30255 | (2S)-2-([[(2-isopropyl-1,3-thiazol-4-yl)methoxy]carbonyl]amino)-3-methylbutyric acid | C13H20N2O4S | 详情 | 详情 | |
(VI) | 30253 | tert-butyl (3S)-3-[(tert-butylamino)carbonyl]-4-((2R,3S)-2-hydroxy-3-[[(2S)-2-([[(2-isopropyl-1,3-thiazol-4-yl)methoxy]carbonyl]amino)-3-methylbutanoyl]amino]-4-phenylbutyl)-1-piperazinecarboxylate | C37H58N6O7S | 详情 | 详情 | |
(VII) | 30254 | (2-isopropyl-1,3-thiazol-4-yl)methyl (1S)-1-[[((1S,2R)-1-benzyl-3-[(2S)-2-[(tert-butylamino)carbonyl]piperazinyl]-2-hydroxypropyl)amino]carbonyl]-2-methylpropylcarbamate | C32H50N6O5S | 详情 | 详情 | |
(VIII) | 28617 | 5-(chloromethyl)-1,3-benzodioxole | C8H7ClO2 | 详情 | 详情 |